Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Pneumoconiosis Companies

ID: MRFR/Pharma/3218-HCR
200 Pages
Vikita Thakur
Last Updated: February 16, 2025
Pneumoconiosis is a group of lung diseases caused by the inhalation of various types of dust over an extended period. These diseases often result from occupational exposure to dust in certain industries. Companies involved in pneumoconiosis-related activities can fall into several categories, including those that produce or use materials generating harmful dust, as well as those engaged in preventive measures, research, and treatment. 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pneumoconiosis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.83%
2024 Market Size$ 1.84 Billion
2025 Market Size$ 1.89 Billion
2035 Market Size$ 2.5 Billion
Key Players
Companies such as Bristol-Myers Squibb
Merck & Co.
Pfizer Inc.
GlaxoSmithKline
AstraZeneca
Novartis AG
Opportunities
  • Rising Incidence of Pneumoconiosis
  • Regulatory Framework and Compliance
  • Economic Factors and Workforce Dynamics

Top Industry Leaders in the Pneumoconiosis Market

Pneumoconiosis Key Companies
 
Latest Pneumoconiosis Companies Update

3M Company Introduced the Versaflo™ M-3000 Powered Air-Purifying Respirator with PAPR and CPAP options, offering enhanced protection against airborne dust particles associated with pneumoconiosis.

MSA Safety Launched the G1 Pro SCBA (Self-Contained Breathing Apparatus) with improved airflow and communication features, crucial for ensuring worker safety in hazardous environments prone to pneumoconiosis-causing dust.

Honeywell International Developed the Smart Wearable Sensor System, monitoring worker exposure to hazardous dust and providing real-time alerts for improved prevention measures against pneumoconiosis.

Honeywell International Acquired Intelligrated Work Solutions, expanding its portfolio of safety and compliance services, including pneumoconiosis prevention programs for workplaces.

DuPont de Nemours Partnered with the National Institute for Occupational Safety and Health (NIOSH) to research and develop innovative dust suppression technologies for mining and construction industries.

List of Pneumoconiosis Key Companies in the Market

  • Abbott (US) Eli Lilly (U.S.)
  • Sunpharma (India)
  • Sanofi (France)
  • Novo Nordisk (Denmark)
  • Novartis (Switzerland)
  • Abbott (U.S.)
  • AstraZeneca (U.K)
  • Merck & Co. (U.S.)
  • Pfizer (U.S.)
  • Svizera Healthcare (India)
  • Hoffman La Roche AG (Germany)
  • Bayer Cropscience Ltd. (U.S.)